The use of erythropoiesis ‐stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - July 9, 2018 Category: Hematology Authors: Elena Cris à , Daniela Cilloni , Elena M. Elli , Vincenzo Martinelli , Giuseppe A. Palumbo , Novella Pugliese , Eloise Beggiato , Chiara Frairia , Marco Cerrano , Giuseppe Lanzarone , Monia Marchetti , Mauro Mezzabotta , Mario Source Type: research